The economic impact of substandard and falsified antimalarial medications in Nigeria.
<h4>Introduction</h4>Substandard and falsified medications pose significant risks to global health. Nearly one in five antimalarials circulating in low- and middle-income countries are substandard or falsified. We assessed the health and economic impact of substandard and falsified antim...
Main Authors: | Sarah M Beargie, Colleen R Higgins, Daniel R Evans, Sarah K Laing, Daniel Erim, Sachiko Ozawa |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2019-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0217910 |
Similar Items
-
Impact of substandard and falsified antimalarials in Zambia: application of the SAFARI model
by: Kathryn D. Jackson, et al.
Published: (2020-07-01) -
Development of an agent-based model to assess the impact of substandard and falsified anti-malarials: Uganda case study
by: Sachiko Ozawa, et al.
Published: (2019-01-01) -
Cost savings of paper analytical devices (PADs) to detect substandard and falsified antibiotics: Kenya case study
by: Hui-Han Chen, et al.
Published: (2021-03-01) -
Substandard and falsified medicine screening technologies
by: Lukas Roth, et al.
Published: (2019-07-01) -
Substandard and Falsified Medicines in Myanmar
by: Mirai Sakuda, et al.
Published: (2020-03-01)